Results 141 to 150 of about 32,692 (251)
A prognostic model for head and neck squamous cell carcinoma based on eosinophil extracellular trap related genes. [PDF]
Han C +5 more
europepmc +1 more source
ABSTRACT Background Circulating mitochondrial DNA is being investigated as a liquid‐biopsy biomarker because of its high copy number and release during cellular stress. However, diagnostic estimates vary across tumor types and assays, and prognostic studies have measured both cell‐free mtDNA and cellular blood‐derived mtDNA, which are not analytically ...
Ziying Zhang +5 more
wiley +1 more source
ZBP1 Drives CD8+ T cell-mediated anti-tumor immunity in head and neck squamous cell carcinoma. [PDF]
Min Y +8 more
europepmc +1 more source
Immunological and metabolic characterization in HNSCC
I Ugele +7 more
openaire +1 more source
ABSTRACT Radiation therapy (RT) is a mainstay of treatment for a myriad of cancers, often utilized for tumors that are unable to be resected, as well as an adjunct to surgery and chemotherapy. Unfortunately, many cancers are resistant to RT‐induced damage and subsequent cell death.
Joseph Carmicheal +4 more
wiley +1 more source
LUCAT1 promotes stemness in head and neck squamous cell carcinoma by sponging miR-128. [PDF]
Wen Y +8 more
europepmc +1 more source
ABSTRACT Purpose Patients unable to receive cisplatin due to age, comorbidities, or reduced performance status are commonly treated with concurrent radiotherapy (RT) and cetuximab. This study evaluated the prognostic significance of the Geriatric 8 (G8) score and the Charlson Comorbidity Index (CCI) in predicting survival outcomes in this population ...
Esin Kiraz +5 more
wiley +1 more source
Antibody-drug conjugates in recurrent or metastatic HNSCC: relevant targets, clinical development, and future prospects. [PDF]
Zhao H +11 more
europepmc +1 more source
Proinflammatory Mediator and EMT in HNSCC [PDF]
openaire +1 more source
ABSTRACT Background It has previously been demonstrated that the nuclear factor of activated T cells (NFAT) is crucial for the development of tumors. Given OSCC's drug resistance and poor outcomes, identifying NFAT‐associated prognostic genes is urgent for better treatment.
Julaiti Tuerxun +2 more
wiley +1 more source

